𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations

✍ Scribed by Kayser, Sabine; Levis, Mark J.

Book ID
120304819
Publisher
Informa plc
Year
2013
Tongue
English
Weight
684 KB
Volume
55
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intolerance to tyrosine kinase inhibitor
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia : Definitions and clinical implications
✍ Javier Pinilla-Ibarz; Jorge Cortes; Michael J. Mauro πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

## Abstract Tyrosine kinase inhibitor (TKI) treatment targeting breakpoint cluster region‐Abelson murine leukemia virus, the cause of chronic myeloid leukemia (CML), has revolutionized therapy for patients with this disease. The majority of patients with CML maintain favorable responses with long‐t